Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022
25 Janeiro 2022 - 10:00AM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader
of life science research and clinical diagnostic products, will
report financial results for the fourth quarter and full year 2021
on Thursday, February 10, 2022, following the close of the market.
The company will discuss these results in a conference call
scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day.
To listen, call 844-200-6205 within the U.S. or 929-526-1599
outside the U.S., access code: 348449. You may also listen to the
conference call live via webcast that is available on the "Investor
Relations" section of our website under "Quarterly Results" at
www.bio-rad.com. A replay of the webcast will be available for up
to a year.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global
leader in developing, manufacturing, and marketing a broad range of
innovative products for the life science research and clinical
diagnostic markets. With a focus on quality and customer service
for 70 years, our products advance the discovery process and
improve healthcare. Our customers are university and research
institutions, hospitals, public health and commercial laboratories,
biotechnology and pharmaceutical companies, as well as applied
laboratories that include food safety and environmental quality.
Founded in 1952, Bio-Rad is based in Hercules, California, and has
a global network of operations with more than 7,800 employees
worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020. For
more information, please visit www.bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220125005485/en/
Investor Contact: Bio-Rad Laboratories, Inc. Edward
Chung, Vice President, Investor Relations 510-741-6104
ir@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Bio Rad Laboratories (NYSE:BIO)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024